Skip to main content

Table 2 Euvolemic hemodialysis patient’s antihypertensive medication and comorbidities (n = 145)

From: Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study

Patient variables

No. (%)

Antihypertensive medication

 ACE-I

12 (8.3)

 ARBs

36 (24.8)

 CCBs

43 (29.7)

 Alpha antagonist

6 (4.1)

 Beta antagonist

42 (29)

 Diuretics

41 (28.3)

Antihypertensive combination therapy

15 (10.3)

Co-morbid conditions

 Hypertension

118 (81.3)

 Diabetes mellitus

97 (66.9)

 Cardiovascular diseases

20 (13.8)

 Cerebrovascular accident

14 (9.7)

 Hyperlipidemia

20 (13.8)

 Gouty arthritis

18 (12.4)

 Other comorbiditiesa

41 (28.3)

  1. ACE-I Angiotensin converting enzyme inhibitors, ARBs Angiotensin receptor blockers, CCBs Calcium channel blockers, aOther comorbidities: Blood clots, depression, asthma, osteoarthritis, pregnancy losses/birth defects and osteoporosis